Patent: 6,552,246
✉ Email this page to a colleague
Summary for Patent: 6,552,246
Title: | Transgenic mice comprising CD45 knockout |
Abstract: | A mammal lacking expression of particular CD45 isoform in certain cells of the immune system is provided. The mammal may optionally contain a transgene encoding the CD45RO isoform. Also provided are methods of using these mammals. |
Inventor(s): | Mak; Tak Wah (Toronto, CA), Penninger; Josef Martin (Toronto, CA) |
Assignee: | University Health Network (Toronto, CA) |
Application Number: | 08/451,318 |
Patent Claims: | see list of patent claims |
Details for Patent 6,552,246
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2020-04-22 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2020-04-22 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2020-04-22 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |